Clinical trials in Braila

Innovative research focusing on atherosclerotic cardiovascular disease prevention through advanced therapeutic approaches. Studies are evaluating new treatments to reduce the risk of major cardiovascular events.

• Primary and Secondary Prevention
• Cardiovascular Death Prevention
• Heart Attack Risk Reduction

Clinical investigations aim to demonstrate the effectiveness of novel medications in preventing adverse cardiovascular outcomes in high-risk patients.

Comprehensive studies examining new therapeutic options for patients with atrial fibrillation, particularly focusing on stroke prevention and systemic embolism reduction.

• Stroke Prevention Therapies
• Alternative Anticoagulation Options
• Bleeding Risk Management

Research targets both standard anticoagulation approaches and solutions for patients unsuitable for conventional treatments.

Groundbreaking research exploring combination therapies for heart failure patients, investigating new treatment approaches to improve patient outcomes.

• Combination Drug Therapy
• Cardiovascular Mortality Reduction
• Emergency Care Prevention

Studies focus on evaluating innovative therapeutic combinations to enhance heart failure management and reduce hospitalizations.